Jeffrey Su

Jeffrey Su has an extensive work history in the pharmaceutical and biotechnology industries. Jeffrey is currently serving as the President of Bioserv Corporation, a leading contract development and manufacturing service provider. Prior to this role, they worked as the EVP & COO at Sorrento Therapeutics, Inc. Jeffrey also held positions as the Chief Scientific and Development Officer at Cytovance Biologics, Co-founder and VP of Operations and Product Development at Femta Pharma, and Deputy Director of Manufacturing Technology and Formulation Leader at Sanofi Pasteur. Additionally, they have held various leadership roles at Amylin Pharmaceuticals, CancerVax, Dow Chemical, Tanox, and Pharming, where they were responsible for process development, tech transfer, and manufacturing operations. Jeffrey Su has demonstrated expertise in project management, process development, and problem-solving within the pharmaceutical and biotechnology sectors.

Jeffrey Su attended Carleton University from 1987 to 1992. However, no information is provided regarding the degree obtained or field of study during this time. Additionally, there is a mention of Nankai University, but no specific dates or details are provided regarding this educational experience.